Wendling, Daniel <br/><br/>
Rituximab treatment for spondyloarthritis. A nationwide series: data from the AIR registry of the French Society of Rheumatology.  [electronic resource] 

 -  The Journal of rheumatology  Dec 2012 
 - 2327-31 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1499-2752 
<br/><br/><label>Standard No.: </label>10.3899/jrheum.120201  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Psoriatic--drug therapy<br/>C-Reactive Protein--analysis<br/>Drug Substitution<br/>Female<br/>France<br/>Health Status<br/>Humans<br/>Joints--drug effects<br/>Male<br/>Middle Aged<br/>Registries<br/>Retrospective Studies<br/>Rituximab<br/>Severity of Illness Index<br/>Spondylitis, Ankylosing--drug therapy<br/>Treatment Outcome<br/>Young Adult